Many nursing home residents still take antipsychotics, studies find

Share this article:

Antipsychotic medication use is still widespread in nursing homes, even after the federal government issued a “black box” warning on the drugs in 2005. That is according to two new studies.

In one study, researchers examined the number of times the subject of antipsychotics was brought up during doctors' office visits. Between January 2003 and March 2005, mentions grew at a rate of 16% among elderly residents with dementia. In the year after the advisory was issued, mentions dropped by 19% among this group. Researchers found that in 2008, antipsychotic use fell dramatically but still represented 9% of all prescriptions in this population.

Another study found that one-third of residents in nursing homes were prescribed antipsychotics and that one-third of that number did not have dementia or psychosis. The drugs in question include clozapine, risperidone, olanzapine and paliperidone. Doctors prescribe these drugs, which are designed to treat bipolar disorder and schizophrenia, off-label for residents with dementia. Both studies appeared in Monday's issue of the Archives of Internal Medicine.


Share this article:

More in News

Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show

Nursing home antipsychotic use has dipped nearly 19% ...

The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.

Jimmo succeeds in getting Medicare coverage, two years after landmark case ended

Glenda Jimmo has reached a settlement with the federal government and will finally receive Medicare coverage for claims that were denied in 2007, which led her to file a class-action lawsuit over the so-called "improvement standard."

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...